A UCSF team, led by bioethicist Bernard Lo, MD, recommends that the National Institutes of Health ethics guidelines for embryonic stem cell research be modified to better protect the rights of individuals donating egg or sperm to patients undergoing in vitro fertilization.
The California Institute for Regenerative Medicine (CIRM) has overcome start-up challenges, been selectively influenced by criticism, and ultimately has adhered to its core mission, according to a new UCSF analysis published in the January issue of the American Journal of Public Health (AJPH). UCSF researchers Joel W. Adelson, MD, PhD, MPH, and Joanna K. Weinberg, JD, LLM, both with the UCSF Institute for Health & Aging, School of Nursing, interviewed major stakeholders—supporters and opponents—and analyzed documents and meeting notes for the analysis.
Tackling health threats and improving quality of life were clearly goals that this year’s student researchers had in mind when selecting their projects, which they presented May 19 at a symposium in Millberry Union.
The J. David Gladstone Institutes today announced that senior investigator Shinya Yamanaka, MD, PhD, also of Kyoto University and a UCSF professor of anatomy, has been awarded the prestigious Shaw Prize for his contributions in reprogramming adult skin cells to pluripotent, embryonic-like stem cells. He will receive half of the $1 million award.
Shinya Yamanaka, MD, PhD